About us

KoVax Ltd. was established in 2003 in order to develop,
manufacture and market a vaccine to eradicate fish diseases.
KoVax has acquired the patent for the CyHV3 (KHV) vaccine (For KOI and Common Carp) and the immune-based diagnostic kit from the Hebrew University and the Israeli Ministry of Agriculture.
Kovax is the only company in the world that produced and markets an efficient and safe vaccine against CyHV3 (KHV) disease.

Comments are closed.